mtor cancer therapy pubmed ncbi abstract proteins regulating mammalian target rapamycin mtor targets mtor kinase overexpressed mutated cancer rapamycin naturally occurring inhibitor mtor number recently developed rapamycin analogs rapalogs consisting synthetically derived compounds minor chemical modifications parent structure inhibit growth cell lines derived multiple tumor types vitro tumor models vivo results clinical trials rapalogs treatment subsets types cancer sporadic responses initial clinical trials based hypothesis general translation inhibition cancer cells beginning understood owing complete understanding dynamics mtor regulation function mtor tumor microenvironment review summarize preclinical clinical data recent discoveries function mtor cancer growth regulation 
